Analyze Diet
Frontiers in veterinary science2022; 9; 1056723; doi: 10.3389/fvets.2022.1056723

One Health surveillance approaches for melioidosis and glanders: The Malaysian perspective.

Abstract: The One Health concept was initiated to promote the integration of human, animal, and environmental ecosystems into healthcare to ensure effective control and the sustainable governance of multifaceted health matters. Climate change, deforestation, and rigorous farming disrupt the environment, which serves as the natural habitat for many animals and microbes, increasing the likelihood of disease transmission between humans and animals. Melioidosis (neglected tropical diseases) and glanders are of humans and animals caused by the gram-negative bacteria Burkholderia pseudomallei and its close relative Burkholderia mallei, respectively. In Malaysia, although melioidosis is endemic, it is not a notifiable disease. Hence, the true prevalence of melioidosis in Malaysia is unknown and varies in different regions of the country, with reported hotspots associated with agriculture-related activities. To date, no incidence of human glanders has been reported in Malaysia, although occupational exposure for equine handlers and veterinary professionals remains a concern. Additionally, antibiotics are widely used in the healthcare and veterinary sectors to treat or prevent B. pseudomallei and B. mallei infections, leading to the emergence of resistance in B. pseudomallei. Lack of surveillance, research, assessment, and management of glanders and melioidosis is a major issue in Malaysia. Proper assessment systems and cross-discipline cooperation are vital to recognize and manage both diseases. Experts and practitioners from clinical and veterinary disciplines, environmentalists, law enforcement, policymakers, researchers, local communities, and other experts need to communicate, collaborate, and coordinate activities to fill the knowledge gap on glanders and melioidosis to reduce morbidity and mortality rates in the country. This review aims to define the organizational and functional characteristics of One Health surveillance approaches for glanders and melioidosis from a Malaysian perspective.
Publication Date: 2022-12-15 PubMed ID: 36590813PubMed Central: PMC9798326DOI: 10.3389/fvets.2022.1056723Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores the importance of an integrated One Health surveillance approach for two diseases, melioidosis and glanders, in Malaysia. The study highlights environmental ecological disruptions causing increased risk of disease transmission and the need for cross-disciplinary collaboration to manage these diseases.

One Health Concept

  • The One Health concept is an initiative designed to integrate facets of human, animal, and environmental ecosystems into health practices. It aims to help ensure effective control and governance of multifaceted health matters.
  • Environmental changes, such as climate change, deforestation, and intense farming practices disrupt natural habitats, potentially increasing the likelihood of disease transmission between animals and humans.

Melioidosis and Glanders

  • Melioidosis and glanders are diseases caused by the Gram-negative bacteria Burkholderia pseudomallei and its close relative Burkholderia mallei, respectively.
  • In Malaysia, melioidosis is endemic, but it is not a notifiable disease. Consequently, the exact prevalence of this disease in the country remains unknown and varies by region. There are reported hotspots associated with agriculture-related activities.
  • Thus far, there have been no reported incidence of human glanders in Malaysia. However, the risk remains among occupational groups such as those handling horses and veterinary professionals.

Healthcare Challenges and Antibiotic Use

  • The common use of antibiotics in healthcare and veterinary sectors to treat or prevent these diseases has led to the emergence of resistance in the bacteria, thereby creating a significant healthcare challenge.
  • The lack of surveillance, research, assessment, and management of both glanders and melioidosis presents major issues in Malaysia’s health system.
  • Implementing proper assessment systems and promoting cooperation across various disciplines are critical to identifying and managing both diseases.

The Need for Integration and Collaboration

  • The research calls for enhanced communication and collaboration among clinical and veterinary experts, environmentalists, law enforcement officers, policymakers, researchers, local communities, and other stakeholders.
  • This collaborative and integrated approach aims to bridge the knowledge gap on glanders and melioidosis, striving to reduce both morbidity and mortality rates within the country.
  • The study concludes by affirming its objective to define the organizational and functional characteristics of One Health surveillance approaches for glanders and melioidosis from the perspective of Malaysia.

Cite This Article

APA
Mariappan V, Vellasamy KM, Anpalagar RR, Lim YM, Zainal Abidin N, Subramaniam S, Nathan S. (2022). One Health surveillance approaches for melioidosis and glanders: The Malaysian perspective. Front Vet Sci, 9, 1056723. https://doi.org/10.3389/fvets.2022.1056723

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 9
Pages: 1056723

Researcher Affiliations

Mariappan, Vanitha
  • Center for Toxicology and Health Risk Studies, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Vellasamy, Kumutha Malar
  • Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Anpalagar, Rohan Raaj
  • Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Lim, Yue-Min
  • Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Zainal Abidin, Nurhamimah
  • Faculty of Applied Sciences, School of Biology, Universiti Teknologi MARA (UiTM), Cawangan Negeri Sembilan, Kuala Pilah, Negeri Sembilan, Malaysia.
Subramaniam, Sreeramanan
  • School of Biological Sciences, Universiti Sains Malaysia (USM), Georgetown, Penang, Malaysia.
  • Chemical Centre Biology, Universiti Sains Malaysia (USM), Bayan Lepas, Penang, Malaysia.
  • National Poison Centre, Universiti Sains Malaysia (USM), Georgetown, Penang, Malaysia.
Nathan, Sheila
  • Faculty of Science and Technology, School of Biosciences and Biotechnology, Universiti Kebangsaan Malaysia, Bangi, Malaysia.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 75 references
  1. The World Bank. (2022). Available online at: https://data.worldbank.org/country/MY (accessed September 1, 2022).
  2. Ministry of Health Malaysia. (1988). Available online at: https://file:///C:/Users/OPTIPLEX%070%20SFF/Downloads/prevention%20and%20control%20of%20infectious%20disease%20act%201988.pdf (accessed August 5, 2022).
  3. Department of Agriculture (DOA). National Action Plan Invasive Alien Species 2021–2. 2021.
  4. World Health Orization. FAO, OIE, and WHO Launch a Guide for Countries On Taking a One Health Approach To Addressing Zoonotic Diseases. 2019.
  5. enters for Disease Control and Prevention. One Health Basics. 2022.
  6. Chua AQ, Verma M, Hsu LY, Legido-Quigley H. An analysis of national action plans on antimicrobial resince in Southeast Asia using a governance framework approach. Lancet Reg Health West Pac (2021) 7:100084.
  7. Malaysia One Health University Network (MyOHUN) . (2022). Malaysia One Health University Network (accessed March 28, 2022).
  8. World Health Organization. Second Report. Technical Report Series, No. 169. nt WHO/FAO Expert Committee on Zoonoses 1959.
    pubmed: 0
  9. Gebreyes WA, Dupouy-Camet J, Newport MJ, Oliveira CJ, Schlesinger LS, Saif YM. The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environt interface in low-resource settings. PLoS Negl Trop Dis 8:e3257.
  10. Rahman MT, Sobur MA, Islam MS, Ievy S, Hossain MJ, El Zowalaty ME. Zoonotic diseases: etiology, impact, and control. Microorganisms 8:1405.
  11. World Health Organization. Joint Enal Evaluation of IHR Core Capacities of Malaysia: Mission Report, 21–25 October 2019. 2020.
  12. Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS. Global morbidity anrtality of leptospirosis: a systematic review. PLoS Negl Trop Dis (2015) 9:e0003898.
  13. Wiersinga WJ, Virk HS, Torres AG, Currie BJ, Peacock SJ, Dance DAB. Melioidosis. Nat Rev Dis Primers 4:17107.
    doi: 10.1038/nrdp.2017.107pmc: PMC6456913pubmed: 29388572google scholar: lookup
  14. Limmathurotsakul D, Golding N, Dance DA, Messina JP, PigoM, Moyes CL. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol (2016) 1:1–5.
    doi: 10.1038/nmicrobiol.2015.8pubmed: 27571754google scholar: lookup
  15. Inglis TJJ. Burkholderia pseudomallei and Burkholderia mallei. Mol Med Microbiol (2015) 2:769–91.
  16. National Resp Team. (2011). Available online at: https://www.nrt.org/sites/2/files/120502_GlandersandMelioidosis_QRG_Final.pdf (accessed November 10,).
  17. Santos Júnior ELD, Moura JCR, Protásio B, Parente VAS. Clinical repercussions of Glanders (Burkhola mallei infection) in a Brazilian child: a case report. Rev Soc Bras Med Trop (2020) 53:e20200054.
    doi: 10.1590/0037-8682-0054-2020pmc: PMC7310367pubmed: 32578712google scholar: lookup
  18. Van Zandt KE, Greer MT. Glanders: an overview of infection in humans. Orphanet J Rare Dis (2013) 8:131.
    doi: 10.1186/1750-1172-8-131pmc: PMC3766238pubmed: 24004906google scholar: lookup
  19. Fhogartaigh CN. Glanders and melioidosis: a zoonosis and a sapronosis “same same, but dient”. Zoonoses - Infections Affecting Humans and Animals: Focus on Public Health Aspects 2015 859–88.
  20. Nathan S, Chieng S, Kingsley PV, Mohan A, Podin Y, Ooi MH. Melioidosis in Malaysia: Incidence, clinical challs, and advances in understanding pathogenesis. Trop. Med. Infect. Dis. (2018) 3:25.
    doi: 10.3390/tropicalmed3010025pmc: PMC6136604pubmed: 30274422google scholar: lookup
  21. Centers for Disease Control and Prevention. Bioterrorism Agents/Diseases. 2018.
  22. Kingsley PV, er M, Nagodawithana NS, Tipre M, Sathiakumar N. Melioidosis in Malaysia: a review of case reports. PLoS Negl Trop Dis (2016) 10:e0005182.
  23. Zueter AR, Yean CY, Abumarzouq M, Rahman ZA, Deris ZZ, Harun A. The emiology and clinical spectrum of melioidosis in a teaching hospital in a north-eastern state of Malaysia: a fifteen-year review. BMC Infect Dis (2016) 16:1–11.
    doi: 10.1186/s12879-016-1583-2pmc: PMC4947242pubmed: 27423906google scholar: lookup
  24. Sapian M, Khairi MT, How SH, Rajalingam R, Sahhir K, Norazah A. Outbreak of melioidosis and leptospirosis co-infectfollowing a rescue operation. Med J Malays (2012) 67:293–7.
    pubmed: 23082420
  25. Shaharudin R, Ahmad N, Kamaluddin MA. Detection of Burkholderia pseudomallei from post-flood soil samples in Kelantan, Malaysia. Southeast Asian J Trop Med Public Health (2016) 47:951–6.
    pubmed: 29620800
  26. Hisham B, Marzukhi M, Daud A. R.. Spectrum of floodrelated diseases encountered durilood disaster in Johore, Malaysia. Malaysian J Commun Health (2009) 15:15–23.
  27. Chen PS, Chen YS, Lin HH, Liu PJ, Ni WF, Hsueh PT. Airborne transmission of melioidosis to humans from environmental aerosols contaminated with B. pseudomallei. PLoS Negl Trop Dis (2015) 9:e0003834.
  28. Musa HI, Hassan L, Shamsuddin ZH, Panchadcharam C, Zakaria Z, Aziz St al.. Physicochemical properties influencing presence of Burkholderia pseudomallei in soil from small ruminant farms in peninsular Malaysia. PLoS ONE (2016) 11:e0162348.
  29. Puthucheary SD. Melioidosis in Malaysia. Med J Malays (2009) 64:266–74.
    pubmed: 20954549
  30. Musa HI, Hassan L, Shamsuddin ZH, Panchadcharam C, Zakaria Z, Abdul Aziz S. Case–control investigation on the risk factors of melioidosis in small ruminant farms in Peninsular Malaysia. J Appl Microbiol (2015) 119:331–41.
    doi: 10.1111/jam.12830pubmed: 25891038google scholar: lookup
  31. Abu Hassan MR, Aziz N, Ismail N, Shafie Z, Mayala B, Donohue RE. Socio-epidemiological and land cover risk factors for melioidosis in Kedah, Northern Malaysia. PLoS Negl Trop Dis (2019) 13:e0007243.
  32. Peacock SJ, Schweizer HP, Dance DA, Smith TL, Gee JE, Wuthiekanun V. Management of accidentaboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis (2008) 14:e2.
    doi: 10.3201/eid1407.071501pmc: PMC2600349pubmed: 18598617google scholar: lookup
  33. Masrin A, Nurul Fatiha AS, Fakhrulisham R, Sharil Azwan MZ. Geographical mapping on seropositive status of melioidosis among livestock in Malaysia from 2012 to 2016. Malaysian J Vet (2018) 9:44–52.
  34. Elschner MC, Hnizdo J, Stamm I, El-Adawy H, Mertens K, Melzer F. Isolation of the highly pathogenic and zoonotic agent Burkholderia pseudomallei from a pet green Iguana in Prague, Czech Republic. BMC Vet Res (2014) 10:283.
    doi: 10.1186/s12917-014-0283-7pmc: PMC4255680pubmed: 25430942google scholar: lookup
  35. Cheng A, Currie B. Melioidosis: epidemiology, pathophysiology, and management. Microbiol Rev (2005) 18:383–416.
  36. Department of Veterinary Services (DVS). Veterinary regulations for temporary importation of horses into Malaysia. 2011.
  37. Jabatan Kesihatan Negeri Pahang (JKNPHG) JKN. Guidelines for Clinical and Public Health Management of Melioidosis in Pahang. .
  38. How SH, Ng TH, Jamalludin AR, Tee HP, Kuan YC, Alex F. Pahang melioidosis registry. Med J Malays (2009) 64:27–30.
    pubmed: 19852316
  39. How SH, Ng KH, Jamalludin AR, Shah A, Rathor Y. Melioidosis in pahang, Malaysia. Med J Malays (2005) 60:606–13.
    pubmed: 16515112
  40. Hassan MRA, Pani SPng NP, Voralu K, Vijayalakshmi N, Mehanderkar R. Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecolol emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect Dis (2010) 10:1–8.
    doi: 10.1186/1471-2334-10-302pmc: PMC2975659pubmed: 20964837google scholar: lookup
  41. Deris ZZ, Hasan H, Siti Suraiya MN. Clinical characteristics and outcomes of bacteraemic melioidosis in a teaching hospital in a northeastern state of Malaysia: a five-year review. J Infect Dev Ctries (2010) 4:430–5.
    doi: 10.3855/jidc.491pubmed: 20818090google scholar: lookup
  42. Pagalavan L. Melioidosis: the johor bahru experience. Med J Malays (2005) 60:605.
    pubmed: 16515111
  43. Murray J, Cohen AL. Infectious disease surveillance. Int Encyclopedia Public Health (2017) 222–9.
  44. Choh LC, Ong GH, Vellasamy KM, Kalaiselvam K, g WT, Al-Maleki AR. Burkholderia vaccines: are we moving forward?. Front Cell Infect Microbiol (2013) 3:5.
    doi: 10.3389/fcimb.2013.00005pmc: PMC3564208pubmed: 23386999google scholar: lookup
  45. Rhodes KA, Schweizer HP. Aiotic resistance in Burkholderia species. Drug Resist Update (2016) 28:82–90.
    doi: 10.1016/j.drup.2016.07.003pmc: PMC5022785pubmed: 27620956google scholar: lookup
  46. Estes D, Dow S, Schweizer H. Present and future therapeutic strategies for melioid and glanders. Expert Rev Anti Infect Ther (2010) 8:325–38.
    doi: 10.1586/eri.10.4pmc: PMC2856610pubmed: 20192686google scholar: lookup
  47. Khosravi Y, Vellasamy KM, Mariappan V, Ng SL, Vadivelu J. Antimicrobial susceptibility and genetic characterisation of Burkholderia pseudomallei isolated from Malaysian patients. Sci World J (2014) 2014:132971.
    doi: 10.1155/2014/132971pmc: PMC4213392pubmed: 25379514google scholar: lookup
  48. Dance D. Treatment and prophylaxis of melioidosis. Int J Antimicrob Agents (2014) 43:310–8.
  49. Podin Y, Sarovich DS, Price EP, Kaestli M, Mayo M, Hii K. Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptito aminoglycosides and macrolides. Antimicrob Agents Chemother (2014) 58:162–6.
    doi: 10.1128/AAC.01842-13pmc: PMC3910780pubmed: 24145517google scholar: lookup
  50. Kenny DJ, Russell P, Rogers D, Eley SM, Titball RW. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pgenic Burkholderia spp. Antimicrob Agents Chemother (1999) 43:2773–5.
    doi: 10.1128/AAC.43.11.2773pmc: PMC89557pubmed: 10543761google scholar: lookup
  51. Heine HS, England MJ, Waag DM, Byrne WR. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. microb Agents Chemother (2001) 45:2119–21.
  52. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. Antibiotic susceptibi of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemotherapy (2004) 54:1134–8.
    doi: 10.1093/jac/dkh471pubmed: 15509614google scholar: lookup
  53. Naureen A, Saqib M, Muhammad F, Ahmad R, Muhammad G, Asi MN. Antimicrobial susceptibility 41 Burkholderia mallei isolates from spontaneous outbreaks of equine glanders in Punjab, Pakistan. J Equine Vet Sci (2010) 30:134–40.
  54. Ahmad N, Hashim R, Mohd Noor A. The in vitro antibioticceptibility of Malaysian isolates of Burkholderia pseudomallei. Int J Microbiol (2013) 2013:121845.
    doi: 10.1155/2013/121845pmc: PMC3803121pubmed: 24194761google scholar: lookup
  55. Hassan MRA, Vijayalakshmi N, Pani SP, Peng NP, Mehenderkar R, Voralu K. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Ke Malaysia. Southeast Asian J Trop Med Public Health (2014) 45:680–8.
    pubmed: 24974653
  56. Chierakul W, Anunnatsiri S, Short JM, Maharjan B, Mootsikapun P, Simpson AJ. Two randomizontrolled trials of ceftazidime alone vs. ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis (2005) 41:1105–13.
    doi: 10.1086/444456pubmed: 16163628google scholar: lookup
  57. Sullivan RP, Marshall CS, Anstey NM, Ward L, Currie BJ. Review and revision of the 2015 Darwinioidosis treatment guideline; paradigmdrift not shift. PLoS Negl Trop Dis (2020) 14:e0008659.
  58. Strauss JM, Groves MG, Mariappan M, Ellison DW. Melioidosis in Malaysia. II Distribution of Pseudomonas pseudomallei in soil and surface water. Am J Trop Med Hyg (1969) 18:698–702.
    doi: 10.4269/ajtmh.1969.18.698pubmed: 5810797google scholar: lookup
  59. Mohan A, Podin Y., N., Chieng C- H., Rigas V., Machunter B.. Pediatric melioidosis in Sarawak, Malaysia: Epidemiological, clinical and microbiological characteristics. PLoS Negl Trop Dis (2017) 11:e0005650.
  60. Hii SYF, Kee CC, Ahmad N. Melioidosiserview of seropositivity in malaysia. Trop Biomed (2016) 33:697–701.
    pubmed: 33579066
  61. Hadi FS, Ghazali S, Ahmad N, Ramli SR. Trend and pattern of melioidosis seropositivity among suspected patients in Malaysia 2015–2019. Trop Biomed (2021) 38:561–67.
    doi: 10.47665/tb.38.4.099pubmed: 35001922google scholar: lookup
  62. Musa HI, Hassan L, Rachmat RFN, Panchadcharam C, Zakaria Z, Abdul Aziz S, l. Seroprevalence of melioidosis among livestock in Malaysia from 2000–2009. Malaysian J Vet Res (2012) 3:41–6.
  63. Hambali I, Abba Y, Bitrus A, Peter I, Jesse-A FF. Seroprevalence of melioidosis in sheep and goats from selected small ruminant s in Selangor, Malaysia. Adv Animal Vet Sci (2018) 6:88–94.
  64. Sari DDK, Busono W, Nugroho HC. Production performance in semiintensive and extensive farming system from Jembrana District, Bali, Indonesia. Res Zool (2016) 6:17–20.
  65. Ministry of Agriculture and Food Industry & Ministry of Energy and Natural Resources Malaysia. National Action Plan on Invasive Alien Species 2021–2025. 2021 p. 84.
  66. Department of Veterinary Services (DVS). Buku Panduan Senarai Penyakit Wajib Lapor, No. Dokumentasi: IPPV/PBS-EpiS:PWL(3)2020. 2020.
  67. Richardson LJ, Kaestli M, Mayo M, Bowers JR, Tuanyok A, Schupp J. Towards a r molecular diagnostic for melioidosis: comparison of DNA extraction methods from clinical specimens. J Microbiol Methods (2012) 88:179–181.
    doi: 10.1016/j.mimet.2011.10.023pmc: PMC3249147pubmed: 22108495google scholar: lookup
  68. Naama T, Zura AH, Chin SW, Mazlan L, Nurul Fatiha AS, Masrin A. Melioidosis in various animal spe diagnosed in the Veterinary Research Institute from 2007 to 2011. 2012.
  69. Vellayan S. Melioidosis in zoo animals in Malaysia. Melioidosis: Prevailing Problems and Future Directions 1994.
  70. Dvorak GD, Spickler AR. Glanders. J Am Vet Med Assoc (2008) 15:233.
    doi: 10.2460/javma.233.4.570pubmed: 18710311google scholar: lookup
  71. Varga JJ, Vigil A, DeShazer D, Waag DM, Felgner P. Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence (2012) 10–4.
    doi: 10.4161/viru.22056pmc: PMC3524150pubmed: 23076276google scholar: lookup
  72. Centers for Disease Control and Prevention. Laboratory-acquired human glanders—Maryland. MMorbidity Mortality Weekly Rep (2000) 49:532–5.
    pubmed: 10923853
  73. Chin AZ, Maluda MCM, Jelip J, Jeffree MS, Culleton R, Ahmed K. Malaria elimination in Malaysia and the rising threat of Plasmodium knowlesi. J Physiol Anthropol (2020) 3.
    doi: 10.1186/s40101-020-00247-5pmc: PMC7686722pubmed: 33228775google scholar: lookup
  74. Al-Abd NM, Nor ZM, Ahmed A, Al-Adhroey AH, Mansor M. Lymphatic filariasis in Peninsular Malaysia: a cross-sectional survey of the knowledge, attitudes, and practiof residents. Parasites Vectors (2014) 7:545.
    doi: 10.1186/s13071-014-0545-zpmc: PMC4253608pubmed: 25428558google scholar: lookup
  75. Verma A, Saminathan MN, Tiwari R, Dhama K, Singh S. Glanders-A re-emerging zoonotisease: a review. J Biol Sci (2014) 14:38–51.
    doi: 10.3923/jbs.2014.38.51google scholar: lookup